Method for loading tumor antigen peptide to dendritic cell (DC) in targeting manner
A tumor antigen peptide, dendritic cell technology, applied in the medical field, can solve problems such as immune stagnation, and achieve the effect of improving ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0021] For the experimental methods not indicated in the following examples, the specific conditions are usually in accordance with conventional conditions, or in accordance with the conditions suggested by the corresponding raw material manufacturers.
[0022] 1. Preparation and biotin labeling of fusion protein V:
[0023] 1. Construction of recombinant gene expression vector:
[0024] Specific measures for recombining the anti-DEC-205 antibody molecule and the tumor antigen peptide MUC1 in the same fusion protein:
[0025] According to the functional diagram and the corresponding nucleic acid sequence, using the method of commercial artificially synthesized nucleic acid, synthesize 744 bases of the antibody molecule (antiDEC-ScFV) with anti-DEC-205, 72 bases of the MUC1 polypeptide (MUC1) and expression Purify 69 bases of the required functional region (TEV, Myc, His6). The synthetic whole gene fragment (855 bases) was cloned into the commercial plasmid vector pET41a(+) b...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com